Abstract
摘要
相似文献
1
Valsartan for hypertension.缬沙坦用于治疗高血压。
Med Lett Drugs Ther. 1997 Apr 25;39(999):43-4.
2
Valsartan/hydrochlorothiazide: pharmacology and clinical efficacy.缬沙坦/氢氯噻嗪：药理学与临床疗效
Expert Opin Drug Metab Toxicol. 2009 Sep;5(9):1125-34. doi: 10.1517/17425250903136730.
3
Coadministration of valsartan 160 and 320 mg and simvastatin 20 and 40 mg in patients with hypertension and hypercholesterolemia: a multicenter, 12-week, double-blind, double-dummy, parallel-group superiority study.缬沙坦160毫克和320毫克与辛伐他汀20毫克和40毫克联合用于高血压和高胆固醇血症患者：一项多中心、为期12周的双盲、双模拟、平行组优效性研究。
Clin Ther. 2008 Oct;30(10):1782-93. doi: 10.1016/j.clinthera.2008.10.004.
4
Aliskiren/valsartan (Valturna) for hypertension.阿利吉仑/缬沙坦（代文缬沙坦胶囊）用于治疗高血压。
Med Lett Drugs Ther. 2009 Nov 30;51(1326):94-5.
5
[New combination of high dosage sartan and 25 mg HCT. Systolic blood pressure lowered by 21 mmHg].
MMW Fortschr Med. 2004 Apr 8;146(15):68.
6
7
[Double profit for hypertensive patients. Blood pressure decreases--frequency of coitus increases].
MMW Fortschr Med. 2003 Aug 21;145(33-34):56.
8
[Sartans for lowering blood pressure. Hypertensive patients need not fear potency].
MMW Fortschr Med. 2002 Apr 25;144(17):48.
9
Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.缬沙坦与氢氯噻嗪两种固定剂量复方制剂与缬沙坦单药治疗对2或3期收缩期高血压患者的降压疗效及耐受性比较：一项为期8周的随机、双盲、平行组试验
Clin Ther. 2005 Jul;27(7):1013-21. doi: 10.1016/j.clinthera.2005.07.010.
10
[Blood pressure lowering and risk reduction under treatment with valsartan and its combination with hydrochlorothiazide (HCT)].缬沙坦及其与氢氯噻嗪（HCT）联合治疗下的血压降低与风险降低
MMW Fortschr Med. 2006 Oct 19;148(42):48.
Zotero 插件